Pelvic Floor Electric Stimulator Market Size & Share 2024 – 2032

Pelvic Floor Electric Stimulator Market Size

Pelvic Floor Electric Stimulator Market size was valued at around USD 244.1 million in 2023 and is estimated to grow at 11.4% CAGR from 2024 to 2032. Pelvic floor electric stimulators are medical devices designed to deliver electrical impulses to the pelvic floor muscles, stimulating them to contract and strengthen. These devices are used to treat various pelvic floor disorders, including urinary incontinence, pelvic organ prolapse, and sexual dysfunction.

The prevalence of urinary incontinence is rising due to a combination of factors, including an aging population, increasing obesity rates, and lifestyle changes that contribute to pelvic floor dysfunction. For instance, the National Library of Medicine reports that the prevalence of urinary incontinence (UI) ranges from 5% to 70% globally, with most studies indicating 25% to 45%. In China, 38% of women experience UI, while in Japan, 44% of women aged 40 and above are affected. Therefore, there is a growing need for effective treatment options that can help manage this condition.
 

Pelvic floor electric stimulators, designed to strengthen the pelvic muscles and improve bladder control, have emerged as a promising solution. Thus, the rising prevalence of urinary incontinence is stimulating the demand for urinary incontinence treatment devices, which is estimated to reach USD 6.5 billion by 2032, as they offer a non-invasive, safe, and effective means of managing symptoms, thereby improving the quality of life for those affected.
 

Furthermore, campaigns such as World Continence Week and National Bladder Health Awareness Week aim to dispel myths, reduce stigma, and encourage individuals to seek treatment. These initiatives highlight the benefits of pelvic floor electric stimulators as effective, non-invasive solutions for strengthening pelvic muscles and improving overall pelvic health.
 

Pelvic Floor Electric Stimulator Market Trends

• The rapidly aging global population is a major accelerator for the market. According to the World Health Organization, by 2030, one in six people worldwide will be 60 years old or older. The share of the population in this age group will rise from 1 billion in 2020 to 1.4 billion. This demographic shift is contributing to a higher prevalence of pelvic floor disorders, as aging leads to weakened muscles and decreased tissue elasticity, increasing the risk of urinary incontinence.
   
• Therefore, there is a growing demand for therapeutic solutions tailored to the elderly. Pelvic floor electric stimulators offer a non-invasive, user-friendly option for strengthening pelvic muscles and improving quality of life for older adults, creating a larger market for these devices.
   
• The healthcare industry's shift towards non-invasive treatments is driven by patient demand for options with less discomfort and recovery time. Pelvic floor electric stimulators meet this need, offering a pain-free alternative to surgery. Their ease of use and cost-effectiveness are increasing their popularity, boosting market growth and innovation.
   

Pelvic Floor Electric Stimulator Market Analysis

Based on product type, the market is divided into mobile and fixed. The mobile segment of the market is forecasted to reach USD 415.9 million by 2032.
 

• Mobile stimulators, with their convenience and portability, empower users to discreetly engage in pelvic floor exercises on the go. This smart home healthcare solution not only boosts accessibility, especially for those in remote areas, but also boasts advanced features such as smartphone connectivity and personalized tracking.
   
• These features not only engage users but also encourage regular use. With the rising smartphone penetration and a growing preference for non-invasive solutions, the segment's growth is poised to accelerate.
   
• Thus, aforementioned factors are anticipated to augment segment growth.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the pelvic floor electric stimulator market is bifurcated into urinary incontinence, neurodegenerative diseases, and sexual dysfunction. The urinary incontinence segment accounted for USD 194.8 million in 2023.
 

• The rising prevalence of urinary incontinence, especially among the elderly, has increased the demand for effective non-invasive treatment options. Patients' preference for conservative treatments and the endorsement of pelvic floor electric stimulators by healthcare professionals have further accelerated their adoption.
   
• Additionally, increased awareness, improved diagnosis rates, and technological advancements have contributed to market growth.
   
• Therefore, as more people seek convenient ways to manage urinary incontinence and enhance their quality of life, the demand for pelvic floor electric stimulators is expected to continue driving market expansion.
   

Based on end-use, pelvic floor electric stimulator market is bifurcated into hospitals, clinics, home care settings, and other end-users. The hospitals segment accounted for USD 128.1 million in 2023.
 

• Hospitals play a crucial role in the adoption of pelvic floor electric stimulators due to their comprehensive healthcare infrastructure, skilled medical professionals, and access to advanced diagnostic tools.
   
• Hospitals offer a wide range of services that cater to both acute and chronic conditions, making them the ideal setting for the administration of pelvic floor stimulation therapies.
   
• Furthermore, hospitals often serve as referral centers, receiving complex cases that cannot be managed in smaller clinics or home care settings. The credibility and trust associated with hospital-based care also contribute to the high patient preference for these facilities.
   

The growth of the pelvic floor electric stimulator market in the U.S., projected to reach USD 245.9 million by 2032.
 

• The U.S. is experiencing a significant increase in its aging population, which is more prone to pelvic floor disorders. For instance, according to the Urban Institute, the number of individuals aged 65 and older is expected to more than double over the next 40 years, reaching 80 million by 2040.
   
• Therefore, as the population ages, the incidence of conditions such as urinary incontinence and pelvic pain rises, stimulating the demand for effective management solutions such as pelvic floor electric stimulators.
   

The pelvic floor electric stimulator market in UK is expected to experience significant and promising growth from 2024 to 2032.
 

• There is a growing recognition of pelvic floor disorders and the benefits of electric stimulation therapy in the country. Public health campaigns and professional education initiatives are enhancing awareness about the impact of conditions such as urinary incontinence, pelvic pain, and post-surgical recovery.
   
• This heightened awareness is stimulating the demand for effective treatment options, including pelvic floor electric stimulators.
   

Japan pelvic floor electric stimulator market is anticipated to witness lucrative growth between 2024 – 2032.
 

• There is a strong preference for non-invasive and drug-free treatment options among Japanese patients. Pelvic floor electric stimulators align with this preference, offering a non-pharmacological approach to managing pelvic floor disorders.
   
• The appeal of avoiding surgery or medications, along with the convenience of home-based therapy, is driving the adoption of these devices.
   

The pelvic floor electric stimulator market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
 

• In Saudi Arabia, the market is benefiting from significant technological advancements that enhance both efficacy and user convenience. Innovations such as intuitive controls, improved patient comfort, and integration with mobile health technologies are making these devices more accessible and effective.
   
• Enhanced features such as ergonomic designs and smart technology, which include automated adjustments based on real-time feedback, are stimulating the patient and provider adoption. These developments are aligning with Saudi Arabia's focus on advanced healthcare technologies, contributing to the growing acceptance and use of pelvic floor electric stimulators in the country.
   

Pelvic Floor Electric Stimulator Market Share

The pelvic floor electric stimulator industry is characterized by intense competition, involving both major global companies and smaller to medium-sized companies vying for market dominance. Key to market strategy is the consistent launch of innovative products utilizing various technologies. Major industry leaders play a significant role in driving innovation by making substantial investments in research and development. Moreover, strategic partnerships, acquisitions, and mergers play crucial roles in strengthening market positions and enhancing international presence.
 

Pelvic Floor Electric Stimulator Market Companies

Some of the eminent market participants operating in the pelvic floor electric stimulator industry include:

• Athena Feminine Technologies, Inc.
• Axena Health, Inc.
• Beacmed s.r.l.
• Chiaro Technology Limited
• Everyway Medical Instruments Co., Ltd.
• InControl Medical.
• Laborie
• Medtronic plc
• Nidd Valley Medical
• PeriCoach
• Shenzhen XFT Medical Limited
• TensCare Ltd
• The Prometheus Group
• Verity Medical Ltd
• Zynex, Inc.
   

Pelvic Floor Electric Stimulator Industry News:

• In July 2024, Axena Health, Inc. (Axena Health), a company specializing in female pelvic health, announced that two major health plans in Pennsylvania and North Dakota have included the Leva Pelvic Health System in their covered benefits for members with urinary incontinence. This strategic move allows Axena Health to access a larger patient base, potentially increasing the adoption of the Leva Pelvic Health System and driving higher sales volumes, which could significantly boost the company’s revenue.
   

The pelvic floor electric stimulator market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Mobile
• Fixed

Market, By Application

• Urinary incontinence
• Neurodegenerative diseases
• Sexual dysfunction

Market, By End-use

• Hospitals
• Clinics
• Home care settings
• Other end-users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America 
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa